Imbio PHA (4.0.0) vs Merlin.net

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Imbio
VS
by Abbott

AI Verdict

Tool A, Imbio PHA, is an AI-powered image processing software designed for analyzing CT pulmonary angiogram scans to aid in the diagnosis and risk stratification of pulmonary embolism and hypertension. In contrast, Tool B, Merlin.net, is a web-based remote monitoring platform specifically for managing data from patients with Abbott's implanted cardiac devices. While both fall under cardiology AI, they address distinct clinical workflows: image-based diagnostics versus remote patient and device management.

Choose Imbio PHA (4.0.0) if…

Choose Imbio PHA (4.0.0) if your primary need is rapid, AI-driven analysis of CT pulmonary angiogram (CTPA) scans to automatically measure cardiac structures. This tool is ideal for radiologists and cardiologists seeking to quickly assess right ventricular dilation and aid in the diagnosis and risk stratification of pulmonary embolism and hypertension from imaging data.

View Imbio PHA (4.0.0) →

Choose Merlin.net if…

Choose Merlin.net if you are a clinician managing patients with Abbott implanted cardiac devices and require a comprehensive remote monitoring platform. This system is best suited for continuous data management, remote follow-up, and receiving proactive alerts for patient events, enabling informed clinical decisions and streamlined patient care.

View Merlin.net →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Imbio PHA (4.0.0) Merlin.net
Pricing Contact for pricing Contact vendor for pricing
Deployment Cloud, Enterprise (on-premise), or via partners Cloud-based (web application)
FDA Status Yes AI-estimated 1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Imbio PHA (4.0.0)

Imbio PHA emphasizes a 'fully automated' and 'no user interfaces to learn' approach, integrating seamlessly into existing DICOM workflows and PACS without requiring active user intervention for analysis. This 'zero-click' functionality provides a highly streamlined experience for radiologists. In contrast, Merlin.net, while web-based and comprehensive, involves active clinician interaction with a platform that some reviews suggest can be clunky or have a steep learning curve.

Clinical Value

Merlin.net

Merlin.net demonstrates significant clinical value through documented improvements in patient outcomes, including more than twice the probability of survival for adherent patients and a reduction of 10 hospitalizations and 119 hospital days per 100 patients annually, leading to substantial cost savings. While Imbio PHA provides critical diagnostic aid for acute conditions like pulmonary embolism and hypertension by standardizing image reads, Merlin.net's evidence of direct impact on patient survival and reduced healthcare utilization gives it a stronger overall clinical value proposition.

Pricing & Value

Tie

Both tools require direct contact with the vendor for pricing information, making it impossible to assess or compare their pricing transparency or overall value proposition without specific financial details.

Enterprise Readiness

Merlin.net

Merlin.net exhibits superior enterprise readiness through its explicit ISO 27001 certification and Service Organization Control (SOC) 2 Type II report, demonstrating robust security and compliance for its cloud-based platform. Furthermore, its recent migration to Microsoft Azure with EU regionalized data processing and residency enhances its appeal for global enterprise adoption. While Imbio PHA offers flexible deployment options including on-premise, Merlin.net's comprehensive, independently validated security and compliance posture for its cloud solution is a key differentiator.

Innovation

Imbio PHA (4.0.0)

Imbio PHA's innovation lies in its core AI-powered automation of complex medical image analysis, specifically for measuring cardiac structures from CTPA scans to aid in the diagnosis and risk stratification of pulmonary embolism and hypertension. This represents a direct technological advancement in objective, quantitative diagnostics. Merlin.net, while innovative in its comprehensive remote patient management ecosystem, focuses more on integrating and optimizing existing functionalities rather than a singular, advanced AI application for a specific diagnostic task.

Support & Docs

Merlin.net

Merlin.net provides comprehensive support resources, including a detailed 'Help Manual' for clinicians, an 'EHRDirectu2122 Integration FAQ,' and dedicated patient technical support via phone and email for its associated devices. Imbio PHA also offers support contacts and user manuals, but Merlin.net's explicitly documented, multi-faceted support infrastructure for both clinicians and patients gives it a slight advantage.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Imbio PHA (4.0.0) Merlin.net
Name Imbio PHA (4.0.0) Merlin.net
Company Imbio Abbott
Description FDA-cleared AI-powered medical image processing software that automatically measures cardiac structures from CT pulmonary angiogram (CTPA) scans to assess potential right ventricular dilation and aid in the diagnosis and risk stratification of pulmonary embolism and hypertension. Web-based remote monitoring platform for clinicians to manage data from patients with implanted cardiac devices, enabling remote follow-up, device performance monitoring, and informed clinical decisions.
Categories Cardiology AI, Radiology & Imaging AI Cardiology AI, Wearables & Remote Monitoring (RPM)
Specialties Cardiology, Pulmonology, Radiology Cardiology
Key Features Automated measurement of right and left ventricle diameters; Automated measurement of main pulmonary artery and aorta diameters; Calculates RV/LV and PA/Ao ratios; Utilizes artificial intelligence algorithms for anatomical identification and measurement; Generates annotated DICOM images; Provides summary reports in PDF format; Integrates with native DICOM tools and workflows; Rapid, fully-automated assessment (typically in minutes) Remote monitoring of Abbott implanted cardiac devices; Web-based interface for clinicians; Data management and review of cardiac information; EHRDirectu2122 data transfer for seamless EHR integration (HL7 standards); DirectAlertsu2122 notification for patient events; SmartScheduleu2122 calendar for follow-up coordination; DirectCallu2122 integrated patient communication; DirectTrendu2122 viewer for dynamic device and clinical trends

Videos

Demos, reviews, and walkthroughs featuring Imbio PHA (4.0.0) and Merlin.net.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Imbio PHA (4.0.0) analyzes cardiac structures from CT pulmonary angiogram (CTPA) scans to provide measurements. In contrast, Merlin.net manages and reviews data from patients with Abbott implanted cardiac devices for remote monitoring.
Imbio PHA (4.0.0) aids in the diagnosis and risk stratification of pulmonary embolism and hypertension by assessing right ventricular dilation from CTPA scans. Merlin.net focuses on remote follow-up, device performance monitoring, and informed clinical decisions for patients with implanted cardiac devices.
Imbio PHA (4.0.0) is relevant for Cardiology, Pulmonology, and Radiology due to its image processing capabilities for CTPA scans. Merlin.net is primarily designed for Cardiology, specifically for managing patients with Abbott implanted cardiac devices.
Imbio PHA (4.0.0) integrates with native DICOM tools and workflows and generates annotated DICOM images. Merlin.net offers EHRDirectu2122 data transfer for seamless EHR integration using HL7 standards.
Imbio PHA (4.0.0) explicitly utilizes artificial intelligence algorithms for anatomical identification and measurement from CTPA scans. While Merlin.net is categorized under 'Cardiology AI', its listed features focus on data management, alerts, and communication for implanted devices rather than AI-driven diagnostic analysis of patient data.
Imbio PHA (4.0.0) supports the assessment of potential right ventricular dilation to aid in the diagnosis and risk stratification of pulmonary embolism and hypertension. Merlin.net is designed for remote monitoring and management of data from Abbott implanted cardiac devices.
AI Tool Finder
AI-powered search. Results may not be comprehensive.